PAVmed Inc.
PAVmed Inc. PAVMW Peers
See (PAVMW) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PAVMW | $0.03 | +105.67% | 769.7K | -0.05 | -$0.58 | N/A |
| ABT | $132.96 | +1.26% | 231.3B | 17.29 | $7.69 | +1.74% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| BSX | $106.15 | +1.58% | 157B | 77.48 | $1.37 | N/A |
| SYK | $383.81 | +1.91% | 146.7B | 52.01 | $7.38 | +0.87% |
| MDT | $81.21 | +0.66% | 104.2B | 22.50 | $3.61 | +3.47% |
| EW | $76.21 | +1.63% | 44.7B | 31.49 | $2.42 | N/A |
| DXCM | $85.33 | +0.97% | 33.5B | 64.16 | $1.33 | N/A |
| STE | $246.18 | +1.31% | 24.2B | 40.03 | $6.15 | +0.92% |
| PODD | $326.40 | +1.57% | 23B | 58.70 | $5.56 | N/A |
Stock Comparison
PAVMW vs ABT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ABT has a market cap of 231.3B. Regarding current trading prices, PAVMW is priced at $0.03, while ABT trades at $132.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ABT's P/E ratio is 17.29. In terms of profitability, PAVMW's ROE is +1.58%, compared to ABT's ROE of +0.24%. Regarding short-term risk, PAVMW is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BSX-PA Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, PAVMW is priced at $0.03, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, PAVMW's ROE is +1.58%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, PAVMW is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BSX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BSX has a market cap of 157B. Regarding current trading prices, PAVMW is priced at $0.03, while BSX trades at $106.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BSX's P/E ratio is 77.48. In terms of profitability, PAVMW's ROE is +1.58%, compared to BSX's ROE of +0.10%. Regarding short-term risk, PAVMW is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs SYK Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, SYK has a market cap of 146.7B. Regarding current trading prices, PAVMW is priced at $0.03, while SYK trades at $383.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas SYK's P/E ratio is 52.01. In terms of profitability, PAVMW's ROE is +1.58%, compared to SYK's ROE of +0.11%. Regarding short-term risk, PAVMW is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs MDT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, MDT has a market cap of 104.2B. Regarding current trading prices, PAVMW is priced at $0.03, while MDT trades at $81.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas MDT's P/E ratio is 22.50. In terms of profitability, PAVMW's ROE is +1.58%, compared to MDT's ROE of +0.09%. Regarding short-term risk, PAVMW is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs EW Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, EW has a market cap of 44.7B. Regarding current trading prices, PAVMW is priced at $0.03, while EW trades at $76.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas EW's P/E ratio is 31.49. In terms of profitability, PAVMW's ROE is +1.58%, compared to EW's ROE of +0.49%. Regarding short-term risk, PAVMW is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs DXCM Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, DXCM has a market cap of 33.5B. Regarding current trading prices, PAVMW is priced at $0.03, while DXCM trades at $85.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas DXCM's P/E ratio is 64.16. In terms of profitability, PAVMW's ROE is +1.58%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, PAVMW is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs STE Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, STE has a market cap of 24.2B. Regarding current trading prices, PAVMW is priced at $0.03, while STE trades at $246.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas STE's P/E ratio is 40.03. In terms of profitability, PAVMW's ROE is +1.58%, compared to STE's ROE of +0.09%. Regarding short-term risk, PAVMW is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs PODD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, PODD has a market cap of 23B. Regarding current trading prices, PAVMW is priced at $0.03, while PODD trades at $326.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas PODD's P/E ratio is 58.70. In terms of profitability, PAVMW's ROE is +1.58%, compared to PODD's ROE of +0.35%. Regarding short-term risk, PAVMW is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs PHG Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, PHG has a market cap of 21.4B. Regarding current trading prices, PAVMW is priced at $0.03, while PHG trades at $23.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas PHG's P/E ratio is 77.00. In terms of profitability, PAVMW's ROE is +1.58%, compared to PHG's ROE of +0.03%. Regarding short-term risk, PAVMW is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ZBH Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ZBH has a market cap of 18.6B. Regarding current trading prices, PAVMW is priced at $0.03, while ZBH trades at $94.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ZBH's P/E ratio is 20.94. In terms of profitability, PAVMW's ROE is +1.58%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, PAVMW is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ABMD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, PAVMW is priced at $0.03, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ABMD's P/E ratio is 65.36. In terms of profitability, PAVMW's ROE is +1.58%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, PAVMW is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ALGN Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ALGN has a market cap of 12.9B. Regarding current trading prices, PAVMW is priced at $0.03, while ALGN trades at $178.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ALGN's P/E ratio is 32.46. In terms of profitability, PAVMW's ROE is +1.58%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, PAVMW is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs SNN Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, SNN has a market cap of 12.6B. Regarding current trading prices, PAVMW is priced at $0.03, while SNN trades at $28.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas SNN's P/E ratio is 30.74. In terms of profitability, PAVMW's ROE is +1.58%, compared to SNN's ROE of +0.08%. Regarding short-term risk, PAVMW is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs SWAV Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, PAVMW is priced at $0.03, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas SWAV's P/E ratio is 78.76. In terms of profitability, PAVMW's ROE is +1.58%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, PAVMW is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs PEN Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, PEN has a market cap of 10.6B. Regarding current trading prices, PAVMW is priced at $0.03, while PEN trades at $272.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas PEN's P/E ratio is 254.89. In terms of profitability, PAVMW's ROE is +1.58%, compared to PEN's ROE of +0.04%. Regarding short-term risk, PAVMW is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs GMED Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, GMED has a market cap of 8.1B. Regarding current trading prices, PAVMW is priced at $0.03, while GMED trades at $59.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas GMED's P/E ratio is 44.48. In terms of profitability, PAVMW's ROE is +1.58%, compared to GMED's ROE of +0.05%. Regarding short-term risk, PAVMW is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BIO-B Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BIO-B has a market cap of 6.7B. Regarding current trading prices, PAVMW is priced at $0.03, while BIO-B trades at $250.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BIO-B's P/E ratio is -3.27. In terms of profitability, PAVMW's ROE is +1.58%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, PAVMW is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BIO Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BIO has a market cap of 6.3B. Regarding current trading prices, PAVMW is priced at $0.03, while BIO trades at $230.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BIO's P/E ratio is -3.01. In terms of profitability, PAVMW's ROE is +1.58%, compared to BIO's ROE of -0.32%. Regarding short-term risk, PAVMW is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BRKR Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BRKR has a market cap of 5.6B. Regarding current trading prices, PAVMW is priced at $0.03, while BRKR trades at $37.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BRKR's P/E ratio is 71.44. In terms of profitability, PAVMW's ROE is +1.58%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, PAVMW is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs GKOS Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, GKOS has a market cap of 5.5B. Regarding current trading prices, PAVMW is priced at $0.03, while GKOS trades at $96.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas GKOS's P/E ratio is -42.70. In terms of profitability, PAVMW's ROE is +1.58%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, PAVMW is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs NARI Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, PAVMW is priced at $0.03, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas NARI's P/E ratio is -59.24. In terms of profitability, PAVMW's ROE is +1.58%, compared to NARI's ROE of -0.18%. Regarding short-term risk, PAVMW is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs IRTC Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, IRTC has a market cap of 4.7B. Regarding current trading prices, PAVMW is priced at $0.03, while IRTC trades at $146.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas IRTC's P/E ratio is -46.91. In terms of profitability, PAVMW's ROE is +1.58%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, PAVMW is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs TMDX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, TMDX has a market cap of 4.3B. Regarding current trading prices, PAVMW is priced at $0.03, while TMDX trades at $128.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas TMDX's P/E ratio is 90.51. In terms of profitability, PAVMW's ROE is +1.58%, compared to TMDX's ROE of +0.22%. Regarding short-term risk, PAVMW is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ITGR Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, PAVMW is priced at $0.03, while ITGR trades at $121.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ITGR's P/E ratio is 56.58. In terms of profitability, PAVMW's ROE is +1.58%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, PAVMW is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs INSP Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, INSP has a market cap of 4.2B. Regarding current trading prices, PAVMW is priced at $0.03, while INSP trades at $143.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas INSP's P/E ratio is 65.32. In terms of profitability, PAVMW's ROE is +1.58%, compared to INSP's ROE of +0.10%. Regarding short-term risk, PAVMW is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs AXNX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, PAVMW is priced at $0.03, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas AXNX's P/E ratio is -709.80. In terms of profitability, PAVMW's ROE is +1.58%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, PAVMW is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs PRCT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, PRCT has a market cap of 3.2B. Regarding current trading prices, PAVMW is priced at $0.03, while PRCT trades at $58.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas PRCT's P/E ratio is -34.63. In terms of profitability, PAVMW's ROE is +1.58%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, PAVMW is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs LIVN Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, LIVN has a market cap of 2.4B. Regarding current trading prices, PAVMW is priced at $0.03, while LIVN trades at $44.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas LIVN's P/E ratio is -10.82. In terms of profitability, PAVMW's ROE is +1.58%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, PAVMW is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs NUVA Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, PAVMW is priced at $0.03, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas NUVA's P/E ratio is 75.00. In terms of profitability, PAVMW's ROE is +1.58%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, PAVMW is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs UFPT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, UFPT has a market cap of 1.8B. Regarding current trading prices, PAVMW is priced at $0.03, while UFPT trades at $236.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas UFPT's P/E ratio is 29.00. In terms of profitability, PAVMW's ROE is +1.58%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, PAVMW is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ATEC Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ATEC has a market cap of 1.8B. Regarding current trading prices, PAVMW is priced at $0.03, while ATEC trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ATEC's P/E ratio is -10.81. In terms of profitability, PAVMW's ROE is +1.58%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, PAVMW is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs CNMD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, CNMD has a market cap of 1.8B. Regarding current trading prices, PAVMW is priced at $0.03, while CNMD trades at $57.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas CNMD's P/E ratio is 15.17. In terms of profitability, PAVMW's ROE is +1.58%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, PAVMW is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs TNDM Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, TNDM has a market cap of 1.4B. Regarding current trading prices, PAVMW is priced at $0.03, while TNDM trades at $21.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas TNDM's P/E ratio is -7.70. In terms of profitability, PAVMW's ROE is +1.58%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, PAVMW is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs HSKA Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, PAVMW is priced at $0.03, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas HSKA's P/E ratio is -62.49. In terms of profitability, PAVMW's ROE is +1.58%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, PAVMW is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs AHCO Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, AHCO has a market cap of 1.3B. Regarding current trading prices, PAVMW is priced at $0.03, while AHCO trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas AHCO's P/E ratio is 16.05. In terms of profitability, PAVMW's ROE is +1.58%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, PAVMW is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs AORT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, AORT has a market cap of 1.2B. Regarding current trading prices, PAVMW is priced at $0.03, while AORT trades at $29.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas AORT's P/E ratio is -57.29. In terms of profitability, PAVMW's ROE is +1.58%, compared to AORT's ROE of -0.07%. Regarding short-term risk, PAVMW is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs SILK Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, PAVMW is priced at $0.03, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas SILK's P/E ratio is -18.96. In terms of profitability, PAVMW's ROE is +1.58%, compared to SILK's ROE of -0.37%. Regarding short-term risk, PAVMW is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs FNA Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, PAVMW is priced at $0.03, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas FNA's P/E ratio is -19.83. In terms of profitability, PAVMW's ROE is +1.58%, compared to FNA's ROE of -0.36%. Regarding short-term risk, PAVMW is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ESTA Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ESTA has a market cap of 1.1B. Regarding current trading prices, PAVMW is priced at $0.03, while ESTA trades at $36.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ESTA's P/E ratio is -11.83. In terms of profitability, PAVMW's ROE is +1.58%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, PAVMW is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs IART Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, IART has a market cap of 1B. Regarding current trading prices, PAVMW is priced at $0.03, while IART trades at $13.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas IART's P/E ratio is -34.53. In terms of profitability, PAVMW's ROE is +1.58%, compared to IART's ROE of -0.03%. Regarding short-term risk, PAVMW is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs INMD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, INMD has a market cap of 1B. Regarding current trading prices, PAVMW is priced at $0.03, while INMD trades at $14.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas INMD's P/E ratio is 6.52. In terms of profitability, PAVMW's ROE is +1.58%, compared to INMD's ROE of +0.25%. Regarding short-term risk, PAVMW is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs CSII Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, CSII has a market cap of 844M. Regarding current trading prices, PAVMW is priced at $0.03, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas CSII's P/E ratio is -20.83. In terms of profitability, PAVMW's ROE is +1.58%, compared to CSII's ROE of -0.14%. Regarding short-term risk, PAVMW is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs SIBN Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, SIBN has a market cap of 792.2M. Regarding current trading prices, PAVMW is priced at $0.03, while SIBN trades at $18.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas SIBN's P/E ratio is -29.51. In terms of profitability, PAVMW's ROE is +1.58%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, PAVMW is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs CRY Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, PAVMW is priced at $0.03, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas CRY's P/E ratio is 425.71. In terms of profitability, PAVMW's ROE is +1.58%, compared to CRY's ROE of -0.07%. Regarding short-term risk, PAVMW is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs IRMD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, IRMD has a market cap of 668.2M. Regarding current trading prices, PAVMW is priced at $0.03, while IRMD trades at $52.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas IRMD's P/E ratio is 33.90. In terms of profitability, PAVMW's ROE is +1.58%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, PAVMW is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs RXST Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, RXST has a market cap of 650.6M. Regarding current trading prices, PAVMW is priced at $0.03, while RXST trades at $16.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas RXST's P/E ratio is -24.26. In terms of profitability, PAVMW's ROE is +1.58%, compared to RXST's ROE of -0.10%. Regarding short-term risk, PAVMW is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BFLY Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BFLY has a market cap of 630.6M. Regarding current trading prices, PAVMW is priced at $0.03, while BFLY trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BFLY's P/E ratio is -8.50. In terms of profitability, PAVMW's ROE is +1.58%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, PAVMW is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs CBLL Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, CBLL has a market cap of 623.8M. Regarding current trading prices, PAVMW is priced at $0.03, while CBLL trades at $17.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas CBLL's P/E ratio is -13.81. In terms of profitability, PAVMW's ROE is +1.58%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, PAVMW is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs AVNS Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, AVNS has a market cap of 591.7M. Regarding current trading prices, PAVMW is priced at $0.03, while AVNS trades at $12.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas AVNS's P/E ratio is -1.55. In terms of profitability, PAVMW's ROE is +1.58%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, PAVMW is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BFLY-WT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BFLY-WT has a market cap of 586.5M. Regarding current trading prices, PAVMW is priced at $0.03, while BFLY-WT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, PAVMW's ROE is +1.58%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, PAVMW is more volatile compared to BFLY-WT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs APEN Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, PAVMW is priced at $0.03, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas APEN's P/E ratio is -9.43. In terms of profitability, PAVMW's ROE is +1.58%, compared to APEN's ROE of -0.85%. Regarding short-term risk, PAVMW is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs KIDS Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, KIDS has a market cap of 523.1M. Regarding current trading prices, PAVMW is priced at $0.03, while KIDS trades at $21.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas KIDS's P/E ratio is -12.00. In terms of profitability, PAVMW's ROE is +1.58%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, PAVMW is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs AXGN Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, AXGN has a market cap of 514.6M. Regarding current trading prices, PAVMW is priced at $0.03, while AXGN trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas AXGN's P/E ratio is -70.62. In terms of profitability, PAVMW's ROE is +1.58%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, PAVMW is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs SMLR Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, SMLR has a market cap of 483.9M. Regarding current trading prices, PAVMW is priced at $0.03, while SMLR trades at $43.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas SMLR's P/E ratio is -18.15. In terms of profitability, PAVMW's ROE is +1.58%, compared to SMLR's ROE of -0.21%. Regarding short-term risk, PAVMW is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs OFIX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, OFIX has a market cap of 450.2M. Regarding current trading prices, PAVMW is priced at $0.03, while OFIX trades at $11.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas OFIX's P/E ratio is -3.11. In terms of profitability, PAVMW's ROE is +1.58%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, PAVMW is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BVS Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BVS has a market cap of 434M. Regarding current trading prices, PAVMW is priced at $0.03, while BVS trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BVS's P/E ratio is -13.62. In terms of profitability, PAVMW's ROE is +1.58%, compared to BVS's ROE of -0.21%. Regarding short-term risk, PAVMW is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs NPCE Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, NPCE has a market cap of 414.6M. Regarding current trading prices, PAVMW is priced at $0.03, while NPCE trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas NPCE's P/E ratio is -15.41. In terms of profitability, PAVMW's ROE is +1.58%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, PAVMW is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs SRDX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, SRDX has a market cap of 412M. Regarding current trading prices, PAVMW is priced at $0.03, while SRDX trades at $28.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas SRDX's P/E ratio is -20.58. In terms of profitability, PAVMW's ROE is +1.58%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, PAVMW is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs SENS Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, SENS has a market cap of 407.3M. Regarding current trading prices, PAVMW is priced at $0.03, while SENS trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas SENS's P/E ratio is -4.91. In terms of profitability, PAVMW's ROE is +1.58%, compared to SENS's ROE of -7.46%. Regarding short-term risk, PAVMW is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs TMCI Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, TMCI has a market cap of 382.8M. Regarding current trading prices, PAVMW is priced at $0.03, while TMCI trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas TMCI's P/E ratio is -7.16. In terms of profitability, PAVMW's ROE is +1.58%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, PAVMW is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs CLPT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, CLPT has a market cap of 354.4M. Regarding current trading prices, PAVMW is priced at $0.03, while CLPT trades at $12.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas CLPT's P/E ratio is -16.50. In terms of profitability, PAVMW's ROE is +1.58%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, PAVMW is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs OM Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, OM has a market cap of 333M. Regarding current trading prices, PAVMW is priced at $0.03, while OM trades at $18.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas OM's P/E ratio is -0.65. In terms of profitability, PAVMW's ROE is +1.58%, compared to OM's ROE of -1.45%. Regarding short-term risk, PAVMW is more volatile compared to OM. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs NNOX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, NNOX has a market cap of 331.2M. Regarding current trading prices, PAVMW is priced at $0.03, while NNOX trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas NNOX's P/E ratio is -5.71. In terms of profitability, PAVMW's ROE is +1.58%, compared to NNOX's ROE of -0.30%. Regarding short-term risk, PAVMW is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs CTKB Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, CTKB has a market cap of 324.9M. Regarding current trading prices, PAVMW is priced at $0.03, while CTKB trades at $2.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas CTKB's P/E ratio is -28.50. In terms of profitability, PAVMW's ROE is +1.58%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, PAVMW is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs VREX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, VREX has a market cap of 324.5M. Regarding current trading prices, PAVMW is priced at $0.03, while VREX trades at $7.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas VREX's P/E ratio is -7.59. In terms of profitability, PAVMW's ROE is +1.58%, compared to VREX's ROE of -0.08%. Regarding short-term risk, PAVMW is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs PACB Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, PACB has a market cap of 273.1M. Regarding current trading prices, PAVMW is priced at $0.03, while PACB trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas PACB's P/E ratio is -0.33. In terms of profitability, PAVMW's ROE is +1.58%, compared to PACB's ROE of -1.70%. Regarding short-term risk, PAVMW is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs VMD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, VMD has a market cap of 260.9M. Regarding current trading prices, PAVMW is priced at $0.03, while VMD trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas VMD's P/E ratio is 22.00. In terms of profitability, PAVMW's ROE is +1.58%, compared to VMD's ROE of +0.10%. Regarding short-term risk, PAVMW is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs MXCT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, MXCT has a market cap of 253M. Regarding current trading prices, PAVMW is priced at $0.03, while MXCT trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas MXCT's P/E ratio is -5.95. In terms of profitability, PAVMW's ROE is +1.58%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, PAVMW is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ZIMV Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ZIMV has a market cap of 245.2M. Regarding current trading prices, PAVMW is priced at $0.03, while ZIMV trades at $8.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ZIMV's P/E ratio is -9.76. In terms of profitability, PAVMW's ROE is +1.58%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, PAVMW is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs CERS Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, CERS has a market cap of 239.9M. Regarding current trading prices, PAVMW is priced at $0.03, while CERS trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas CERS's P/E ratio is -12.55. In terms of profitability, PAVMW's ROE is +1.58%, compared to CERS's ROE of -0.35%. Regarding short-term risk, PAVMW is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs TCMD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, TCMD has a market cap of 227.1M. Regarding current trading prices, PAVMW is priced at $0.03, while TCMD trades at $9.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas TCMD's P/E ratio is 14.80. In terms of profitability, PAVMW's ROE is +1.58%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, PAVMW is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs NVRO Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, PAVMW is priced at $0.03, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas NVRO's P/E ratio is -1.91. In terms of profitability, PAVMW's ROE is +1.58%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, PAVMW is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs TLSI Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, TLSI has a market cap of 211.5M. Regarding current trading prices, PAVMW is priced at $0.03, while TLSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas TLSI's P/E ratio is -5.08. In terms of profitability, PAVMW's ROE is +1.58%, compared to TLSI's ROE of +1.07%. Regarding short-term risk, PAVMW is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs EYES Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, EYES has a market cap of 210M. Regarding current trading prices, PAVMW is priced at $0.03, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas EYES's P/E ratio is N/A. In terms of profitability, PAVMW's ROE is +1.58%, compared to EYES's ROE of -0.26%. Regarding short-term risk, PAVMW is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BWAY Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BWAY has a market cap of 201.1M. Regarding current trading prices, PAVMW is priced at $0.03, while BWAY trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BWAY's P/E ratio is 48.41. In terms of profitability, PAVMW's ROE is +1.58%, compared to BWAY's ROE of +0.06%. Regarding short-term risk, PAVMW is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs QTRX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, QTRX has a market cap of 197.6M. Regarding current trading prices, PAVMW is priced at $0.03, while QTRX trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas QTRX's P/E ratio is -4.10. In terms of profitability, PAVMW's ROE is +1.58%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, PAVMW is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs MASS Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, MASS has a market cap of 195.3M. Regarding current trading prices, PAVMW is priced at $0.03, while MASS trades at $5.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas MASS's P/E ratio is -2.45. In terms of profitability, PAVMW's ROE is +1.58%, compared to MASS's ROE of -0.13%. Regarding short-term risk, PAVMW is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs CVRX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, CVRX has a market cap of 181.5M. Regarding current trading prices, PAVMW is priced at $0.03, while CVRX trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas CVRX's P/E ratio is -3.25. In terms of profitability, PAVMW's ROE is +1.58%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, PAVMW is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs CATX Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, CATX has a market cap of 179.3M. Regarding current trading prices, PAVMW is priced at $0.03, while CATX trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas CATX's P/E ratio is -1.96. In terms of profitability, PAVMW's ROE is +1.58%, compared to CATX's ROE of -0.27%. Regarding short-term risk, PAVMW is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs INGN Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, INGN has a market cap of 178M. Regarding current trading prices, PAVMW is priced at $0.03, while INGN trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas INGN's P/E ratio is -5.76. In terms of profitability, PAVMW's ROE is +1.58%, compared to INGN's ROE of -0.15%. Regarding short-term risk, PAVMW is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs SGHT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, SGHT has a market cap of 177.9M. Regarding current trading prices, PAVMW is priced at $0.03, while SGHT trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas SGHT's P/E ratio is -3.51. In terms of profitability, PAVMW's ROE is +1.58%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, PAVMW is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BDMD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BDMD has a market cap of 175.6M. Regarding current trading prices, PAVMW is priced at $0.03, while BDMD trades at $4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BDMD's P/E ratio is 10.03. In terms of profitability, PAVMW's ROE is +1.58%, compared to BDMD's ROE of +0.12%. Regarding short-term risk, PAVMW is more volatile compared to BDMD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs BSGM Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, BSGM has a market cap of 175M. Regarding current trading prices, PAVMW is priced at $0.03, while BSGM trades at $6.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas BSGM's P/E ratio is -12.09. In terms of profitability, PAVMW's ROE is +1.58%, compared to BSGM's ROE of +7.10%. Regarding short-term risk, PAVMW is more volatile compared to BSGM. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs AVR Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, AVR has a market cap of 172.5M. Regarding current trading prices, PAVMW is priced at $0.03, while AVR trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas AVR's P/E ratio is -2.42. In terms of profitability, PAVMW's ROE is +1.58%, compared to AVR's ROE of -2.92%. Regarding short-term risk, PAVMW is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ELMD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ELMD has a market cap of 170.8M. Regarding current trading prices, PAVMW is priced at $0.03, while ELMD trades at $20.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ELMD's P/E ratio is 25.78. In terms of profitability, PAVMW's ROE is +1.58%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, PAVMW is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs LUCD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, LUCD has a market cap of 165M. Regarding current trading prices, PAVMW is priced at $0.03, while LUCD trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas LUCD's P/E ratio is -1.30. In terms of profitability, PAVMW's ROE is +1.58%, compared to LUCD's ROE of +26.96%. Regarding short-term risk, PAVMW is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs LNSR Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, LNSR has a market cap of 161.7M. Regarding current trading prices, PAVMW is priced at $0.03, while LNSR trades at $13.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas LNSR's P/E ratio is -2.79. In terms of profitability, PAVMW's ROE is +1.58%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, PAVMW is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs RCEL Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, RCEL has a market cap of 160.5M. Regarding current trading prices, PAVMW is priced at $0.03, while RCEL trades at $6.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas RCEL's P/E ratio is -2.77. In terms of profitability, PAVMW's ROE is +1.58%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, PAVMW is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ANIK Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ANIK has a market cap of 159.8M. Regarding current trading prices, PAVMW is priced at $0.03, while ANIK trades at $11.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ANIK's P/E ratio is -14.85. In terms of profitability, PAVMW's ROE is +1.58%, compared to ANIK's ROE of -0.33%. Regarding short-term risk, PAVMW is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs PROF Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, PROF has a market cap of 158.5M. Regarding current trading prices, PAVMW is priced at $0.03, while PROF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas PROF's P/E ratio is -4.36. In terms of profitability, PAVMW's ROE is +1.58%, compared to PROF's ROE of -0.70%. Regarding short-term risk, PAVMW is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs RPID Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, RPID has a market cap of 155.6M. Regarding current trading prices, PAVMW is priced at $0.03, while RPID trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas RPID's P/E ratio is -3.45. In terms of profitability, PAVMW's ROE is +1.58%, compared to RPID's ROE of -0.56%. Regarding short-term risk, PAVMW is more volatile compared to RPID. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs LUNG Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, LUNG has a market cap of 124.2M. Regarding current trading prices, PAVMW is priced at $0.03, while LUNG trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas LUNG's P/E ratio is -2.14. In terms of profitability, PAVMW's ROE is +1.58%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, PAVMW is more volatile compared to LUNG. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs MYO Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, MYO has a market cap of 113M. Regarding current trading prices, PAVMW is priced at $0.03, while MYO trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas MYO's P/E ratio is -22.43. In terms of profitability, PAVMW's ROE is +1.58%, compared to MYO's ROE of -0.36%. Regarding short-term risk, PAVMW is more volatile compared to MYO. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ICAD Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ICAD has a market cap of 103.9M. Regarding current trading prices, PAVMW is priced at $0.03, while ICAD trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ICAD's P/E ratio is -19.92. In terms of profitability, PAVMW's ROE is +1.58%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, PAVMW is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs HJLI Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, PAVMW is priced at $0.03, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas HJLI's P/E ratio is N/A. In terms of profitability, PAVMW's ROE is +1.58%, compared to HJLI's ROE of -0.51%. Regarding short-term risk, PAVMW is more volatile compared to HJLI. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs XTNT Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, XTNT has a market cap of 97.4M. Regarding current trading prices, PAVMW is priced at $0.03, while XTNT trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas XTNT's P/E ratio is -7.77. In terms of profitability, PAVMW's ROE is +1.58%, compared to XTNT's ROE of -0.27%. Regarding short-term risk, PAVMW is more volatile compared to XTNT. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs MGRM Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, MGRM has a market cap of 95.3M. Regarding current trading prices, PAVMW is priced at $0.03, while MGRM trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas MGRM's P/E ratio is -5.34. In terms of profitability, PAVMW's ROE is +1.58%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, PAVMW is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.
PAVMW vs ASXC Comparison
PAVMW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PAVMW stands at 769.7K. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, PAVMW is priced at $0.03, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PAVMW currently has a P/E ratio of -0.05, whereas ASXC's P/E ratio is -1.12. In terms of profitability, PAVMW's ROE is +1.58%, compared to ASXC's ROE of -4.07%. Regarding short-term risk, PAVMW is more volatile compared to ASXC. This indicates potentially higher risk in terms of short-term price fluctuations for PAVMW.